Rationale for IL-15 superagonists in cancer immunotherapy-Reference-Cited by-同舟云学术

Rationale for IL-15 superagonists in cancer immunotherapy

Published:2020-03-11 Issue:7 Volume:20 Page:705-709
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Knudson Karin M.¹,Hodge James W.¹,Schlom Jeffrey¹^ORCID,Gameiro Sofia R.¹^ORCID

Affiliation:

1. Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Funder

Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1738379

Reference37 articles.

1. The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications

2. Common gamma chain cytokines and CD8 T cells in cancer

3. The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy

4. The potential and promise of IL-15 in immuno-oncogenic therapies

5. Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection;European Urology;2024-08

2. Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors;Seminars in Immunopathology;2024-07-25

3. Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets;International Journal of Molecular Sciences;2024-06-13

4. Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach;Translational Oncology;2024-06

5. Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma;Science Translational Medicine;2024-05-29